Global /Taiwan /Healthcare /Pharmaceutical Retailers /6929
chevron_leftBack
We Can Medicines Co., Ltd. logo

We Can Medicines Co., Ltd.

6929
TPEX: 6929 Delayed
26.30TWD -3%
0.8333 USD
As of 9 June 2026, We Can Medicines Co., Ltd. has a market cap of $38.68M USD, ranking #32426 globally and #1975 in Taiwan. It ranks #2925 in the Healthcare sector, and #51 in the Pharmaceutical Retailers industry.
Global Rank
32426
Country Rank
1975
Sector Rank
2925
Industry Rank
51
Key Stats
Market Cap
$38.68MUSD
1.22B TWD
Enterprise Value
$67.58MUSD
2.13B TWD
Revenue (TTM)
$102.03MUSD
3.22B TWD
EBITDA (TTM)
-$25.32KUSD
-799.0K TWD
Net Income (TTM)
-$2.32MUSD
-73.21M TWD
EBITDA Margin
0%
Profit Margin
-2.3%
PS Ratio
0.4
PB Ratio
1.2
EV/EBITDA
8.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Pharmaceutical Retailers
CEO
De-Lan Wen open_in_new
Employees
1,005
Founded
1972
Website
yourchance.com.tw open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-3% -7.5% -15% -23% -9.5% -16%

News

Loading...

Markets

Exchange Ticker Price
Taipei Exchange
MIC: ROCO
PRIMARY
6929
佑全藥品股份有限公司
ISIN: TW0006929003
Shares Out.:
45.09M1
TV:
SA:
YF:
GF:
BA:
MS:
26.30 TWD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About We Can Medicines Co., Ltd.

We Can Medicines Co., Ltd. operates a chain of drug stores in Taiwan. The company offers medicine, health food, maternal and baby product, beauty care products, and medical equipment. It sells its products through retail stores and online under the VITALPLUS and Sapporo brands. The company was formerly known as Shenglin Pharmaceutical Co., Ltd. The company was founded in 1972 and is headquartered in Taichung, Taiwan. We Can Medicines Co., Ltd. operates as a subsidiary of Yousheng Medical Technology Co., Ltd.

Similar Companies

Industry: Pharmaceutical Retailers (Global)
Name
Market Cap diff.
PE
CVS
$107.53B
278K%
58.3
$18.59B
145.64B HKD
48K%
24.3
$10.37B
27K%
-
RADL3
$7.41B
38.53B BRL
19K%
28.2
$6.08B
974.65B JPY
16K%
14.9
$5.89B
944.48B JPY
15K%
16.9
chevron_leftBack